现实世界二线治疗模式的不可切除或晚期肝癌在中国:一个追溯的数据库研究研究

Jiahua Leng1,2, Jing Wu3, Rong Han4

  • 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Gastrointestinal Center, Unit III, Peking University Cancer Hospital and Institute, Beijing, China.

PubMed
概括

向治疗,特别是雷戈拉费尼布,是中国最常见的晚期肝癌二线治疗方法. 现实数据显示,在国家药物补偿清单更新后,治疗模式发生了变化.